SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
PERSEUS Trial Results Demonstrate Positive Safety and Efficacy Outcomes for Boston Scientific Corporation's Novel Platinum Chromium TAXUS(R) Element(TM) Stent System